VeriMom¿Es salicyloyl pentapeptide-33 seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specific to salicyloyl pentapeptide‑33, and no peer‑reviewed reproductive toxicity data located. As a large peptide conjugate with no specific evidence of systemic reproductive toxicity, default hazard/mechanism scores are 0. The salicyloyl moiety raises a theoretical consideration (salicylates can have systemic effects at high exposure), but no data indicate that topical use of this peptide leads to relevant maternal exposure (sources checked: ECHA Annex VI, SCCS/CIR repositories, PubMed, PubChem, CosIng, EWG).
Related ingredients
Frequently asked questions
- ¿Es salicyloyl pentapeptide-33 seguro durante el embarazo?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specific to salicyloyl pentapeptide‑33, and no peer‑reviewed reproductive toxicity data located. As a large peptide conjugate with no specific evidence of systemic reproductive toxicity, default hazard/mechanism scores are 0. The salicyloyl moiety raises a theoretical consideration (salicylates can have systemic effects at high exposure), but no data indicate that topical use of this peptide leads to relevant maternal exposure (sources checked: ECHA Annex VI, SCCS/CIR repositories, PubMed, PubChem, CosIng, EWG).
- ¿Es salicyloyl pentapeptide-33 seguro durante la lactancia?
- No data on transfer into breastmilk or lactation effects were found. Given the molecule class (peptidic cosmetic ingredient with likely low dermal absorption) and absence of reproductive/lactation signals in regulatory/search sources, hazard and mechanism scores default to 0 and exposure is judged negligible for typical topical cosmetic use.
- ¿Es salicyloyl pentapeptide-33 seguro para la piel del bebé?
- No infant‑specific toxicity data found. Because the ingredient is not demonstrably non‑absorbable and infant skin has higher surface‑area‑to‑weight and immature barrier, exposure score is increased by +1 (adult e=0 → infant e=1). No evidence specific to developmental or dermatologic hazard in 0–3 yr olds was identified.
- ¿Cómo puntúa VeriMom a salicyloyl pentapeptide-33?
- VeriMom puntúa salicyloyl pentapeptide-33 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a salicyloyl pentapeptide-33 en el embarazo?
- Consulta nuestra lista de alternativas seguras a salicyloyl pentapeptide-33 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.